Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.

  • Icu Medical's Income towards Parent Company rose 9437.59% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7 million, marking a year-over-year increase of 9220.05%. This contributed to the annual value of -$117.7 million for FY2024, which is 29685.72% down from last year.
  • As of Q3 2025, Icu Medical's Income towards Parent Company stood at -$1.9 million, which was up 9437.59% from $32.5 million recorded in Q2 2025.
  • Icu Medical's Income towards Parent Company's 5-year high stood at $32.5 million during Q2 2025, with a 5-year trough of -$39.5 million in Q1 2024.
  • For the 5-year period, Icu Medical's Income towards Parent Company averaged around -$5.4 million, with its median value being -$9.9 million (2023).
  • In the last 5 years, Icu Medical's Income towards Parent Company plummeted by 55569.22% in 2024 and then skyrocketed by 25183.13% in 2025.
  • Quarter analysis of 5 years shows Icu Medical's Income towards Parent Company stood at $19.9 million in 2021, then tumbled by 177.97% to -$15.5 million in 2022, then decreased by 10.37% to -$17.1 million in 2023, then tumbled by 38.96% to -$23.8 million in 2024, then soared by 92.22% to -$1.9 million in 2025.
  • Its Income towards Parent Company stands at -$1.9 million for Q3 2025, versus $32.5 million for Q2 2025 and -$15.5 million for Q1 2025.